Cowen and Company’s Oracle ORCL Stock Holding History

Cowen and Company’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,000	Closed	-$122K	–	703
2021 Q4	$122K	Buy	+50,000	New	+$4.69M	0.01%	351

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cowen and Company's ORCL Position: Q1 2024 in Review

Cowen and Company sold out of Oracle (ORCL) in Q1 2024, closing a stake of 53,863 shares — an estimated $5.68M sold.

Cowen and Company first reported a position in ORCL in Q4 2023 and held it in 1 quarter. The position peaked at $5.68M in Q4 2023. 2,811 funds tracked by Wall St. Rank hold ORCL as of Q1 2024.

Cowen and Company reported no remaining Oracle position as of Q1 2024 after selling out during the quarter.
Cowen and Company sold 53,863 Oracle shares in Q1 2024, an estimated $5.68M.
Cowen and Company first reported a position in Oracle in Q4 2023 and held it in 1 quarter.
Cowen and Company's Oracle position peaked at $5.68M in Q4 2023.
2,811 funds tracked by Wall St. Rank held Oracle as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.